Lingumelt (Loperamide Hydrochloride)

Loperamide Hydrochloride acts as a peripheral µ‑opioid receptor agonist in the gastrointestinal tract. By binding these receptors, it decreases smooth‑muscle activity, slows peristalsis, and promotes absorption of water and electrolytes, thereby limiting the volume and frequency of stools.

The dose of Lingumelt is individualized by the prescribing clinician based on the severity of symptoms, patient age, and clinical response. Typical adult regimens start with an initial dose followed by additional doses as needed, but the exact schedule should be determined by a healthcare professional.

Safety data for Loperamide Hydrochloride in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made in consultation with a qualified healthcare provider.

To order Lingumelt, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

The primary alternative to Loperamide is diphenoxylate combined with atropine. Both reduce intestinal motility, but Loperamide has minimal central nervous system activity and a lower risk of opioid‑related side effects, whereas diphenoxylate may cause more sedation and requires stricter monitoring.

Lingumelt should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and direct light. Keep the product out of reach of children and avoid storing it in humid or excessively hot environments.

Lingumelt is taken orally, usually with a full glass of water. It can be taken with or without food, but patients are advised to follow the dosing instructions provided by their prescriber and to avoid crushing or chewing the tablets unless specifically directed.

Serious risks include severe constipation, intestinal obstruction (ileus), toxic megacolon, allergic reactions such as rash or swelling, and cardiac arrhythmias like QT prolongation. Patients should seek immediate medical attention if they experience abdominal pain, bloating, or any signs of an allergic response.

Lingumelt is contraindicated in children under 2 years of age, individuals with known hypersensitivity to loperamide, patients with acute dysentery or bacterial gastroenteritis, and those with a history of severe constipation or intestinal blockage. It should also be avoided in patients taking certain CYP3A4 or P‑glycoprotein inhibitors without medical supervision.